Navigation Links
PAREXEL to Address New Regulatory Guidelines and Data Standards at DIA EuroMeeting
Date:3/22/2012

challenges of cell-based therapeutics, the new regulation 1394/2007NRalf Hess, PhD, MSc, Principal Consultant (11:00)
  • Session 0807:  Quality Requirements for Clinical TrialsNSusanne Franke, MSc, Senior Manager, Clinical Logistics (14:00)
  • Session 0808:  Metal Catalysts and Others: Analytical and Safety Assessment Demands for Pharmaceuticals Emerging from Regulatory GuidelinesÑAnders Neil, PhD, Principal Consultant (16:00)
  • For more information about PAREXEL visit www.PAREXEL.com or Stands 326 and 328 during the meeting. Information about the DIA EuroMeeting can be found at http://www.diahome.org.

    About PAREXEL International
    PAREXEL International Corporation is a leading global biopharmaceutical services organization, providing a broad range of knowledge-based contract research, consulting, and medical communications services to the worldwide pharmaceutical, biotechnology and medical device industries. Committed to providing solutions that expedite time-to-market and peak-market penetration, PAREXEL has developed significant expertise across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, clinical trials management, medical education and reimbursement.  Perceptive Informatics, Inc., a subsidiary of PAREXEL, provides advanced technology solutions, including medical imaging, to facilitate the clinical development process.  Headquartered near Boston, Massachusetts, PAREXEL operates in 71 locations throughout 52 countries around the world, and has approximately 11,300 employees. For more information about PAREXEL International visit www.PAREXEL.com.

    This release contains "forward-looking" statements regarding future results and events, including, without limitation, statements regarding expected fi
    '/>"/>

    SOURCE PAREXEL International Corporation
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. PAREXEL Global Survey Results Identify Top Concerns of Biopharma Industry in Achieving Commercial Success
    2. PAREXEL International to Present at Barclays Capital Healthcare Conference
    3. PAREXEL International to Present at Cowen Healthcare Conference and Raymond James Investors Conference
    4. PAREXEL to Address Innovative Approaches to Late Stage Development at Summit for Clinical Ops Executives
    5. PAREXEL Expands Alliance Network to Support Early Phase Patient Studies, Establishes Collaboration With University Hospitals Bristol NHS Foundation Trust
    6. PAREXEL Announces Date of Second Quarter Fiscal Year 2012 Earnings Release and Conference Call
    7. PAREXEL Strengthens Late Phase and Observational Research Capabilities With Expert Team to Help Biopharma Meet Commercialization Goals
    8. PAREXEL Advances Early Phase CNS Research Capabilities With Leading Medical Imaging Technology
    9. UCB and PAREXEL Sign Strategic Partnership Agreement
    10. PAREXEL International to Present at Lazard Capital Markets Healthcare Conference and Citi Small/Mid Cap Conference
    11. PAREXEL Commercialization Experts to Present Best-Practice Approaches for Demonstrating Product Value at ISPOR Annual European Congress
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/26/2014)... 25, 2014 Halozyme Therapeutics, Inc. (NASDAQ: ... Conference in New York on Wednesday, ... Dr. Helen Torley , President and Chief Executive ... will be webcast through the "Investors" section of Halozyme,s corporate ... made available for 90 days following the event. To access ...
    (Date:11/24/2014)...  CryoLife, Inc. (NYSE: CRY ), a leading ... vascular surgery, announced today that it will participate in the ... Wednesday, December 3, 2014 at The New York Palace Hotel ... A live webcast of the Company,s presentation is scheduled to ... of the company by Pat Mackin , President and ...
    (Date:11/24/2014)... Nov. 24, 2014 /PRNewswire/ - Milestone Pharmaceuticals, Inc. today ... in Melbourne, Australia of ... potential treatment of paroxysmal supraventricular tachycardia (PSVT).  The ... was well tolerated at single doses up to ... profile, desirable PK properties including rapid onset, and ...
    Breaking Medicine Technology:Halozyme Therapeutics To Present At The Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 2CryoLife to Present at 26th Annual Piper Jaffray Healthcare Conference 3Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 2Milestone Announces Positive Phase 1 Data for MSP-2017; Supports Advancement into Phase 2 in PSVT Patients 3
    ... Calif., Feb. 28, 2011 WaferGen Biosystems, Inc. (OTC ... of state-of-the-art genomic analysis systems, today announced that industry ... Pediatrics at the University of Southern California (USC) Keck ... of WaferGen. "Dr. Triche joined our ...
    ... ALTO, Calif., Feb. 28, 2011 Varian Medical Systems, Inc. ... entered into a new agreement with Bank of America N.A. ... accelerated share repurchase program.   Under the accelerated ... America N.A. and receive approximately 3.5 million shares, or 85% ...
    Cached Medicine Technology:WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 2WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 3WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 4WaferGen Appoints Industry Leader Dr. Timothy J. Triche to Board of Directors 5Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase 2Varian Medical Systems Announces New $280 Million Accelerated Stock Repurchase 3
    (Date:11/26/2014)... (HealthDay News) -- Teens prescribed anti-anxiety or sleep ... drugs than other teens, a new study warns. ... substance abuse assessments on teenagers before prescribing these ... and parents don,t realize the abuse potential," said ... University of Michigan School of Nursing. "These drugs ...
    (Date:11/26/2014)... HealthDay Reporter TUESDAY, Nov. 25, ... Nexium may disrupt the makeup of bacteria in the digestive ... a small new study suggests. The research doesn,t ... become ill, and study authors aren,t recommending that anyone stop ... "should be used at the lowest dose that provides adequate ...
    (Date:11/24/2014)... November 24, 2014 The Healthy Skin ... reviews of affordable skin care products, recently announced its ... offers readers a wide variety of articles, tips, and ... as organic skincare alternatives. , According to Emily Lataille, ... main content includes thoroughly researched reviews, tips for the ...
    (Date:11/24/2014)... 2014 Abington Health is ... has joined The Neurology Group and has been named ... , A graduate of Vinnica Medical University in ... Einstein Medical Center in Philadelphia and completed a fellowship ... Center at Weill Cornell Medical College. Ternopolska is board ...
    (Date:11/24/2014)... (PRWEB) November 24, 2014 Recently, SweetDressy.com, ... industry, unveiled its new collection of 2014 Evening Dresses. ... now. According to the company’s marketing manager, the special ... http://www.sweetdressy.com/evening-dresses.html for more. , Sweetdressy.com has been working ... pleased to unveil the latest designs. Their new dresses ...
    Breaking Medicine News(10 mins):Health News:Teens Given Anxiety, Sleep Meds May Be at Risk for Drug Abuse 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 2Health News:Could Popular Heartburn Drugs Upset Your 'Good' Gut Bugs? 3Health News:Skin Care Advice Blog The Healthy Skin Care Journal Now Accessible to the Public 2Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:SweetDressy.com Unveiled A New Selection Of Evening Dresses 2
    ... (October 28, 2010) University of Minnesota Medical School ... a correlation between increased circuit activity in the right ... triggered by post traumatic stress disorder (PTSD). The ... neural activity, its impact and its manifestation is the ...
    ... News) -- Improving mothers, literacy skills may boost the ... study. U.S. researchers concluded that a mother,s reading ... critical factor influencing her children,s future academic success, even ... neighborhood income. For their study, the researchers examined ...
    ... American Academy of Pediatrics (AAP) recommends that parents limit combined ... 2 hours per day for preschool-age children. In a ... Pediatrics , researchers found that many children are exposed to ... with 66% exceeding the recommended daily amount. According to ...
    ... opinion polls, including newly released data, shows that those who ... in 2010 and those who say they intend to vote ... of what they want the future of health reform legislation ... in Congress on this issue. Nearly three-fourths (73%) ...
    ... Oct. 27 (HealthDay News) -- When it comes to feelings, ... People tend to have worse and more intense views on ... that have already taken place. The observation touches upon ... people apparently take more extreme positions regarding events that have ...
    ... evolution in action in cancer cells. They show the ... only is cancer genetically different between different patients, but ... has acquired distinct mutations. Effectively, ten different ... tumours. The complexity of pancreatic cancer genetics uncovered in ...
    Cached Medicine News:Health News:U of M researchers identify possible key to treating, understanding post-traumatic stress disorder 2Health News:Moms' Literacy Pivotal to Kids' Academic Success 2Health News:New study suggests most preschool-age children exceed daily screen time recommendations 2Health News:Prospective voters and the new health care law 2Health News: Future Seems to Be Viewed More Harshly Than Past 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 2Health News:Forces for cancer spread: Genomic instability and evolutionary selection 3
    Transcranil vascular DWL doppler....
    ... The Nicolet VersaLab ... or line-operated Doppler system ... peripheral vasculature. Crisp, clear ... complemented with a display ...
    ... The Blackstone Spinal Fixation ... fixation system that provides ... spinal stabilization. It combines ... and stability with a ...
    ... Equation System incorporates a semi-rigid design that ... is a reduced-volume and top-tightening spinal instrumentation ... fixation that mimics the load distribution of ... to share, not bear, the load). Stabilizes ...
    Medicine Products: